Product
Protein Expression Analysis
Aliases
protein expression analysis
8 clinical trials
11 indications
Indication
Head and Neck CancerIndication
Breast CancerIndication
Breast Cancer (HER2-positive)Indication
Ovarian Epithelial Cancer, Stage IIIIndication
Ovarian Germ Cell TumorIndication
Ovarian Epithelial CancerIndication
LeukemiaIndication
solid tumorIndication
Protocol SpecificIndication
Liver CancerIndication
lung cancerClinical trial
Multimodality Management of Head and Neck Cancer: A Phase II Trial of Induction Chemotherapy, Organ Preservation Surgery, and Concurrent ChemoradiotherapyStatus: Active (not recruiting), Estimated PCD: 2017-02-14
Clinical trial
Low-Dose Tamoxifen for Radiation-Induced Breast Cancer Risk Reduction: A Phase IIB Randomized Placebo-Controlled TrialStatus: Active (not recruiting), Estimated PCD: 2018-12-11
Clinical trial
A Phase I Study of a DNA Plasmid Based Vaccine Encoding the HER-2/Neu Intracellular Domain in Subjects With HER-2/Neu (HER2) Overexpressing TumorsStatus: Active (not recruiting), Estimated PCD: 2010-03-01
Clinical trial
Neoadjuvant Therapy and Biomarker Analysis of Stage II and III Breast Cancer With Docetaxel/Capecitabine and Celecoxib Followed by Doxorubicin/Cyclophosphamide and CelecoxibStatus: Terminated, Estimated PCD: 2009-07-31
Clinical trial
Multidrug Resistance Protein Gene Polymorphisms in Acute Myeloid Leukemia. A CALGB Leukemia Tissue Bank ProjectStatus: , Estimated PCD: 2100-01-01
Clinical trial
A Phase I Study of AEG35156 Given as a 2 Hour Intravenous Infusion in Combination With Docetaxel in Patients With Solid TumoursStatus: Completed, Estimated PCD: 2009-03-24
Clinical trial
A Phase II Study of Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Bevacizumab (A Monoclonal Antibody to Vascular Endothelial Growth Factor-A), in Patients With Unresectable Primary Hepatic MalignancyStatus: Completed, Estimated PCD: 2024-05-07